Key facts
- It has raised $13.3M; the latest was Leveraged Recapitalization in Mar 2026.
- Notable investors include Revelstoke Capital Partners, Ridgemont Equity Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for AOM Infusion
- ·The full record, as it builds
Funding rounds
No funding rounds for AOM Infusion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AOM Infusion
Provider of home infusion and intravenous therapy services designed to support patients with chronic and acute medical conditions. The company offers IVIG therapy, pharmacy support, referral coordination, insurance assistance, skilled nursing care, and patient education, enabling individuals, families, and healthcare professionals to access efficient, cost-effective treatment in the comfort of their home.
- Sector
- Healthcare
- HQ
- Fort Worth, TX, United States
- Founded
- 1994
- Employees
- 141
- Website
- americanoutcomes.com/
- Ownership
- Privately Held (backing)
AOM Infusion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AOM Infusion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AOM Infusion in its N-PORT filings yet. We sweep new filings monthly.